Streetbeat News

Products Services

ABBV

GSK

NVO

PFE

TEVA

The U.S. Department of Health and Human Services has released final guidance for the second cycle of the Medicare Drug Price Negotiation Program, expected to save $1.5 billion in out-of-pocket costs for Medicare recipients. The program will negotiate prices for up to 15 additional drugs, including those from Novo Nordisk, Pfizer, GSK, Teva, and Abbvie, with new prices effective in 2027.

Portfolio Pulse from Vandana Singh

October 03, 2024 | 2:22 pm

HYMTF

TSLA

WKSP

Ford, GM, and Hyundai are adapting differently to the evolving EV market. Ford focuses on hybrids, GM expands its EV portfolio, and Hyundai maintains EV sales momentum. Ford's EV sales grew but lost its lead to GM, while Hyundai collaborates with Worksport for innovative solutions.

Portfolio Pulse from Upwallstreet

October 03, 2024 | 2:20 pm

VVPR

VivoPower's subsidiary, Tembo, has entered a definitive agreement with Sarao Motors to provide electric jeepneys in the Philippines' $10B market. This partnership aims to electrify the iconic jeepneys, reducing carbon emissions and modernizing public transport.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 2:10 pm

IBKR

Interactive Brokers (NASDAQ:IBKR) is launching Forecast Contracts on US election outcomes, allowing investors to hedge against political volatility. These contracts will be available on the ForecastEx exchange starting October 3, 5:15 pm ET.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 2:03 pm

ANGO

BILI

HIMS

JOBY

LEVI

NGVT

WOLF

Several US-listed stocks experienced significant declines on Thursday, including AngioDynamics, Ingevity, Levi Strauss, and others. AngioDynamics reported a smaller-than-expected loss but still saw a 15.6% drop in share price. Ingevity's CEO departure led to a 12.6% decline. Levi Strauss reported disappointing sales and issued lower guidance, resulting in a 9.1% drop. Other stocks like Hims & Hers Health, Joby Aviation, and several US-listed Chinese stocks also saw declines.

Portfolio Pulse from Avi Kapoor

October 03, 2024 | 2:02 pm

GOVX

SNGX

The WHO Chief has assessed the risk of a Marburg virus outbreak as very high at the national level, high at the regional level, and low at the global level. This assessment may impact companies involved in vaccine development or virus containment.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 2:01 pm

APIE

AVIV

JOBY

Toyota is delaying its North American EV production to 2026 due to slowing sales and design adjustments. The company plans to launch 10 new EV models by 2026 and has reduced its EV production target. Toyota also announced a $500 million investment in Joby Aviation for electric air taxis.

Portfolio Pulse from Lekha Gupta

October 03, 2024 | 1:56 pm

NKE

Nike reported its fiscal first quarter results, surpassing earnings estimates but missing revenue expectations. The company is undergoing a CEO change and is refocusing on wholesale relationships after a less successful direct-to-consumer strategy. Foot Locker, a key partner, is also working on improving its business.

Portfolio Pulse from Upwallstreet

October 03, 2024 | 1:55 pm

BABA

BIDU

NIO

PDD

XPEV

Chinese stocks are cooling off after a significant rally due to stimulus optimism. Concerns over Middle East tensions are causing a pullback in U.S.-listed Chinese stocks like Alibaba, JD.com, Baidu, and others. Despite the pullback, these stocks have seen substantial gains over the past month.

Portfolio Pulse from Adam Eckert

October 03, 2024 | 1:49 pm

KSCP

Knightscope, Inc. (NASDAQ:KSCP) has announced three new expansion contracts for its Emergency Communication Devices with counties in California, Tennessee, and Virginia. These contracts involve scaling up existing agreements to include more devices and long-term services.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2024 | 1:41 pm